Intravenous Nitroglycerin, Methemoglobinemia, and Respiratory Distress in a Postoperative Cardiac Surgical Patient

1984 ◽  
Vol 61 (4) ◽  
pp. 464-465 ◽  
Author(s):  
Andrew M. Zurick ◽  
Reinhard H. Wagner ◽  
Norman J. Starr ◽  
Bruce Lytle ◽  
Fawzy G. Estafanous
Keyword(s):  
Respiratory Distress ◽  
Surgical Patient ◽  
Cardiac Surgical Patient ◽  
Intravenous Nitroglycerin

THE CARDIAC SURGICAL PATIENT

CHEST Journal ◽  
1971 ◽  
Vol 59 (4) ◽  
pp. 472
Author(s):  
Jean Kendrick
Keyword(s):  
Surgical Patient ◽  
Cardiac Surgical Patient

Treatment of Congestive Heart Failure with Intravenous Nitroglycerin in Three Dogs with Degenerative Valvular Disease

2020 ◽  
Vol 56 (1) ◽  
pp. 37-41
Author(s):  
Ron Achiel ◽  
Andy Carver ◽  
Robert A. Sanders
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Mitral Valve ◽  
Adverse Events ◽  
Respiratory Distress ◽  
Intravenous Nitroglycerin ◽  
Constant Rate Infusion ◽  
Optimal Dosing ◽  
Constant Rate ◽  
Rate Infusion

ABSTRACT We described the use of IV nitroglycerin as adjunctive therapy in three canine patients with left congestive heart failure secondary to degenerative mitral valve disease. All three dogs were admitted for signs of respiratory distress and all were determined to be in left congestive heart failure by history, exam findings, thoracic radiographs, and echocardiography. In addition to standard therapy for left congestive heart failure, IV nitroglycerin was administered as a constant rate infusion at a dose of 1–6 mcg/kg/min. No adverse events attributable to the drug were noted. This is the first reported use of IV nitroglycerin in clinical veterinary patients. Further studies are warranted to investigate the safety, efficacy, and optimal dosing of IV nitroglycerin infusions in dogs with left congestive heart failure.

Sign in / Sign up

Export Citation Format

Share Document